Company Overview
General information about the Astellas Pharma company
Astellas Pharma is a Japanese pharmaceutical company that was created in 2005 through the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. The company focuses on the research, development, and commercialization of pharmaceutical products in a variety of therapeutic areas, including immunology, oncology, and urology.
One of Astellas Pharma's primary areas of focus is in the development of treatments for oncology-related diseases. They have a strong portfolio of oncology products, including treatments for prostate, bladder, and pancreatic cancer. In addition, the company is also committed to developing treatments for rare diseases, such as Duchenne muscular dystrophy and acute myeloid leukemia.
Astellas Pharma also has a global presence, with operations in Asia, Europe, North America, and Latin America. They operate research and development centers in Japan, the United States, and the Netherlands, as well as manufacturing facilities in various countries.
Overall, Astellas Pharma is dedicated to improving the health and well-being of patients worldwide through the development of innovative and effective pharmaceutical products.
What is special about the Astellas Pharma company?
There are a few things that are special about Astellas Pharma as a company:
1. Strength in research and development: Astellas Pharma has a strong focus on research and development, with a significant portion of its revenues being invested in this area. This has allowed them to develop innovative medicines and treatments for a wide range of illnesses and conditions.
2. Global presence: Astellas Pharma is a truly global company, with locations and operations in over 50 countries worldwide. This has enabled them to reach a broad market and provide their products and services to a diverse range of patient populations.
3. Patient-centric approach: Astellas Pharma prioritizes the needs and well-being of patients above all else. They strive to understand the needs of patients and work to develop treatments that address their specific conditions.
4. Commitment to sustainability: The company has a strong commitment to sustainability, implementing eco-friendly practices and initiatives in its operations and production processes. They also work to ensure ethical and responsible business practices.
5. Collaborative partnerships: Astellas Pharma believes in collaboration and working with other companies, organizations, and individuals to achieve their mission of improving the lives of patients. They have formed partnerships with various academic institutions, research organizations, and other pharma companies to advance healthcare innovation.
6. Corporate social responsibility: Astellas Pharma is committed to giving back to the community and improving people's lives through its corporate social responsibility initiatives. This includes investing in education, promoting employee diversity and inclusion, and supporting local communities.
Interesting facts about the Astellas Pharma company
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9LV3F3ZnNj OHV1WDJmaHo1eHZNQi53 ZWJwIiBhbHQ9IkFzdGVs bGFzIFBoYXJtYSIgdGl0 bGU9IkFzdGVsbGFzIFBo YXJtYSIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEFzdGVs bGFzIFBoYXJtYT8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
What is the Astellas Pharma company's primary line of business?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9LV3F3ZnNj OHV1WDJmaHo1eHZNQi53 ZWJwIiBhbHQ9IkFzdGVs bGFzIFBoYXJtYSIgdGl0 bGU9IkFzdGVsbGFzIFBo YXJtYSIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEFzdGVs bGFzIFBoYXJtYT8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
What is the market opportunity of the Astellas Pharma company?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9LV3F3ZnNj OHV1WDJmaHo1eHZNQi53 ZWJwIiBhbHQ9IkFzdGVs bGFzIFBoYXJtYSIgdGl0 bGU9IkFzdGVsbGFzIFBo YXJtYSIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEFzdGVs bGFzIFBoYXJtYT8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
SWOT analysis of the Astellas Pharma company
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9LV3F3ZnNj OHV1WDJmaHo1eHZNQi53 ZWJwIiBhbHQ9IkFzdGVs bGFzIFBoYXJtYSIgdGl0 bGU9IkFzdGVsbGFzIFBo YXJtYSIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEFzdGVs bGFzIFBoYXJtYT8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
Porter's Five Forces analysis for the Astellas Pharma company
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9LV3F3ZnNj OHV1WDJmaHo1eHZNQi53 ZWJwIiBhbHQ9IkFzdGVs bGFzIFBoYXJtYSIgdGl0 bGU9IkFzdGVsbGFzIFBo YXJtYSIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEFzdGVs bGFzIFBoYXJtYT8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
What is the Astellas Pharma company's business model?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9LV3F3ZnNj OHV1WDJmaHo1eHZNQi53 ZWJwIiBhbHQ9IkFzdGVs bGFzIFBoYXJtYSIgdGl0 bGU9IkFzdGVsbGFzIFBo YXJtYSIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEFzdGVs bGFzIFBoYXJtYT8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
What is the Astellas Pharma company's unique selling proposition?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9LV3F3ZnNj OHV1WDJmaHo1eHZNQi53 ZWJwIiBhbHQ9IkFzdGVs bGFzIFBoYXJtYSIgdGl0 bGU9IkFzdGVsbGFzIFBo YXJtYSIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEFzdGVs bGFzIFBoYXJtYT8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
How does the Astellas Pharma company differentiate itself in the market?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9LV3F3ZnNj OHV1WDJmaHo1eHZNQi53 ZWJwIiBhbHQ9IkFzdGVs bGFzIFBoYXJtYSIgdGl0 bGU9IkFzdGVsbGFzIFBo YXJtYSIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEFzdGVs bGFzIFBoYXJtYT8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
What are the Astellas Pharma company's potential challenges in the industry?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9LV3F3ZnNj OHV1WDJmaHo1eHZNQi53 ZWJwIiBhbHQ9IkFzdGVs bGFzIFBoYXJtYSIgdGl0 bGU9IkFzdGVsbGFzIFBo YXJtYSIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEFzdGVs bGFzIFBoYXJtYT8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
What challenges did the Astellas Pharma company face in the recent years?
CiAgICAgICAgICAgIDxk aXYgc3R5bGU9J3dpZHRo OiAxMDAlOyBkaXNwbGF5 OiBmbGV4OyBqdXN0aWZ5 LWNvbnRlbnQ6IGNlbnRl cjsnPgogICAgICAgICAg ICAgICAgPGRpdiBzdHls ZT0nCiAgICAgICAgICAg ICAgICAgICAgZGlzcGxh eTogZmxleDsKICAgICAg ICAgICAgICAgICAgICBh bGlnbi1pdGVtczogY2Vu dGVyOwogICAgICAgICAg ICAgICAgICAgIGJhY2tn cm91bmQtY29sb3I6ICNm MGY0Zjg7CiAgICAgICAg ICAgICAgICAgICAgYm9y ZGVyOiAxcHggc29saWQg I2QxZTNmMDsKICAgICAg ICAgICAgICAgICAgICBi b3JkZXItcmFkaXVzOiAx MHB4OwogICAgICAgICAg ICAgICAgICAgIHBhZGRp bmc6IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg bWFyZ2luOiAyMHB4IDA7 CiAgICAgICAgICAgICAg ICAgICAgZm9udC1mYW1p bHk6ICJTZWdvZSBVSSIs IFJvYm90bywgc2Fucy1z ZXJpZjsKICAgICAgICAg ICAgICAgICAgICBib3gt c2hhZG93OiAwIDJweCA2 cHggcmdiYSgwLCAwLCAw LCAwLjA1KTsKICAgICAg ICAgICAgICAgICAgICBt YXgtd2lkdGg6IDkwMHB4 OwogICAgICAgICAgICAg ICAgICAgIHdpZHRoOiAx MDAlOyc+CgogICAgICAg ICAgICAgICAgICAgIDwh LS0gWVlZOiBJbnNlcnQg eW91ciBsb2dvIGltYWdl IGhlcmUgLS0+CiAgICAg ICAgICAgICAgICAgICAg PGltZyBzcmM9ImFzc2V0 cy9sb2dvcy9LV3F3ZnNj OHV1WDJmaHo1eHZNQi53 ZWJwIiBhbHQ9IkFzdGVs bGFzIFBoYXJtYSIgdGl0 bGU9IkFzdGVsbGFzIFBo YXJtYSIgY2xhc3M9Imlt Zy1mbHVpZCIgaGVpZ2h0 PTkwIHdpZHRoPTkwIGxv YWRpbmc9J2xhenknPgoK ICAgICAgICAgICAgICAg ICAgICA8ZGl2IHN0eWxl PSdmbGV4OiAxOyB0ZXh0 LWFsaWduOiBjZW50ZXI7 IG1hcmdpbi1sZWZ0OiA1 cHg7Jz4KICAgICAgICAg ICAgICAgICAgICAgICAg PHAgc3R5bGU9J2ZvbnQt c2l6ZTogMjZweDsgY29s b3I6ICMzMzM7IG1hcmdp bi1ib3R0b206IDE1cHg7 Jz4KICAgICAgICAgICAg ICAgICAgICAgICAgICAg IFdhbnQgdG8gcmVhZCBt b3JlIGFib3V0IEFzdGVs bGFzIFBoYXJtYT8KICAg ICAgICAgICAgICAgICAg ICAgICAgPC9wPgoKICAg ICAgICAgICAgICAgICAg ICAgICAgPGEgaHJlZj0n aW5kZXgucGhwP3BhZ2U9 c2lnbnVwJyBzdHlsZT0n CiAgICAgICAgICAgICAg ICAgICAgICAgICAgICBi YWNrZ3JvdW5kLWNvbG9y OiAjMDA3QkZGOwogICAg ICAgICAgICAgICAgICAg ICAgICAgICAgY29sb3I6 ICNmZmY7CiAgICAgICAg ICAgICAgICAgICAgICAg ICAgICBwYWRkaW5nOiAx MHB4IDIwcHg7CiAgICAg ICAgICAgICAgICAgICAg ICAgICAgICBib3JkZXIt cmFkaXVzOiA1cHg7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IG5v bmU7CiAgICAgICAgICAg ICAgICAgICAgICAgICAg ICBmb250LXdlaWdodDog Ym9sZDsKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG1hcmdpbi1yaWdo dDogMTBweDsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIHRyYW5zaXRp b246IGJhY2tncm91bmQt Y29sb3IgMC4zcyBlYXNl OycKICAgICAgICAgICAg ICAgICAgICAgICAgICAg IG9ubW91c2VvdmVyPSd0 aGlzLnN0eWxlLmJhY2tn cm91bmRDb2xvcj0iIzAw NTZiMyIKICAgICAgICAg ICAgICAgICAgICAgICAg ICAgIG9ubW91c2VvdXQ9 J3RoaXMuc3R5bGUuYmFj a2dyb3VuZENvbG9yPSIj MDA3QkZGIj4KICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIFNpZ24gdXAg Zm9yIGZyZWUKICAgICAg ICAgICAgICAgICAgICAg ICAgPC9hPgoKICAgICAg ICAgICAgICAgICAgICAg ICAgPHNwYW4gc3R5bGU9 J21hcmdpbjogMCA4cHg7 IGNvbG9yOiAjNTU1Oyc+ b3I8L3NwYW4+CgogICAg ICAgICAgICAgICAgICAg ICAgICA8YSBocmVmPSdp bmRleC5waHA/cGFnZT1s b2dpbicgc3R5bGU9Jwog ICAgICAgICAgICAgICAg ICAgICAgICAgICAgY29s b3I6ICMwMDdCRkY7CiAg ICAgICAgICAgICAgICAg ICAgICAgICAgICB0ZXh0 LWRlY29yYXRpb246IHVu ZGVybGluZTsKICAgICAg ICAgICAgICAgICAgICAg ICAgICAgIGZvbnQtd2Vp Z2h0OiA1MDA7Jz4KICAg ICAgICAgICAgICAgICAg ICAgICAgICAgIGxvZyBp bgogICAgICAgICAgICAg ICAgICAgICAgICA8L2E+ CiAgICAgICAgICAgICAg ICAgICAgPC9kaXY+CiAg ICAgICAgICAgICAgICA8 L2Rpdj4KICAgICAgICAg ICAgPC9kaXY+CgogICAg ICAgICAgICA=
